Archived Newsletters

  1. 08.17.19 -- Bury The Hatch-Waxman: Generics Were Not The Answer
    8/17/2019
    08/17/19 Outsourced Pharma Newsletter
  2. 08.14.19 -- Bury The Hatch-Waxman: Generics Were Not The Answer
    8/14/2019
    08/14/19 Outsourced Pharma Newsletter
  3. 08.12.19 -- Oral Formulation Development Strategies
    8/12/2019
    08/12/19 Outsourced Pharma Newsletter
  4. 08.08.19 -- 5 Ways To Optimize Biomanufacturing Process Efficiency Now
    8/8/2019
    08/08/19 Outsourced Pharma Newsletter
  5. 08.07.19 -- What If Our Generics Strategy Has Been All Wrong?
    8/7/2019
    08/07/19 Outsourced Pharma Newsletter
  6. 08.06.19 -- Thinking Outside Of The Freezer: Considerations In Logistics
    8/6/2019
    08/06/19 Outsourced Pharma Newsletter
  7. 08.05.19 -- Keys To Successful Technology Transfers
    8/5/2019
    08/05/19 Outsourced Pharma Newsletter
  8. 07.31.19 -- The New Outsourcers: Amylyx And The Next-Gen Biotechs
    7/31/2019
    07/31/19 Outsourced Pharma Newsletter
  9. 07.25.19 -- Small Molecule: Market Overview, CMO Quality Benchmarking, And Manufacturing Practices
    7/25/2019
    07/25/19 Outsourced Pharma Newsletter
  10. 07.24.19 -- "We Do Everything" CDMO Pitch Not Pleasing Everybody
    7/24/2019
    07/24/19 Outsourced Pharma Newsletter